A Trial to Learn if Odronextamab Combined With Chemotherapy is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Chemotherapy for Adult Participants With Follicular Lymphoma
Clinical trial NCT06097364 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06097364
- Sponsor
- Regeneron Pharmaceuticals
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-14
- Primary completion
- 2029-07-29
- Enrollment
- 733
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.